Greenberg Traurig, LLP Shareholders David J. Dykeman, Matthew J. Levinstein, and David M. Magee presented the MassMEDIC webinar, “Patent Litigation Readiness: Protecting Your Medtech Product” Dec. 4. The webinar offered practical guidance to help medtech leaders protect innovation, manage risk, and strengthen their competitive position. Attendees learned:
-
The latest trends in patent litigation
-
How the evolving USPTO patent policies impact medtech litigation
-
Key steps to manage risk, reduce exposure, and safeguard intellectual property
-
Best practices for financing and preparing for high-stakes disputes
Dykeman is co-chair of Greenberg Traurig’s Global Life Sciences & Medical Technology Group and co-managing shareholder of the Boston office. He focuses on securing worldwide intellectual property protection and related business strategies for high-tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology. He provides strategic patent portfolio development and intellectual property advice for clients, including major research institutions, multinational corporations, and startup companies. He serves on the board of directors of MassMEDIC and previously served on the editorial advisory board for Medical Device & Diagnostic Industry (MD+DI) Magazine.
Levinstein, a shareholder in Greenberg Traurig’s Chicago office practicing in the firm’s Intellectual Property Litigation Group, is an experienced IP litigator, trial attorney, and trusted counselor. He represents clients nationwide in federal district courts, guiding them through every phase of litigation. He has secured early settlements and wins at summary judgment, trial, and on appeal. Levinstein’s diverse technical experience spans numerous industries and technologies, including medical devices, remote controls, wireless communications, television displaces, lawnmowers, hand tools, power tools, baby products, sporting goods, food packaging, kitchen appliances, and other consumer and industrial software, electronics, and mechanical devices. Levinstein also handles high-stakes proceedings before the Patent Trial and Appeal Board (PTAB) and the Trademark Trial and Appeal Board (TTAB).
Magee is a shareholder in Greenberg Traurig’s Boston office and a member of the Intellectual Property & Technology Group. He represents technology and life sciences clients in IP matters, including patent litigation, licensing, and counseling. With more than two decades of experience, he advises companies ranging from startups to multitrillion-dollar corporations and has litigated before the International Trade Commission, PTAB, and U.S. district courts. An engineer by training, Magee leverages his technical background to navigate complex technologies in high-stakes disputes.
About Greenberg Traurig’s Boston Office: Greenberg Traurig’s Boston office is home to more than 100 attorneys practicing in the areas of banking and finance, corporate, emerging technology, energy, environmental, gaming, governmental affairs, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, real estate, restructuring and bankruptcy, tax, and white collar defense and investigations. An important contributor to the firm’s international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. Working collaboratively with the firm’s global network, the Boston team collectively offers clients decades of experience advising on complex legal matters and providing hands-on knowledge of the local business community.
About Greenberg Traurig: Greenberg Traurig, LLP has more than 3,000 lawyers across 51 locations in the United States, Europe, the Middle East, Latin America, and Asia. The firm’s broad geographic and practice range enables the delivery of innovative and strategic legal services across borders and industries. Recognized as a 2025 BTI “Best of the Best Recommended Law Firm” by general counsel for trust and relationship management, Greenberg Traurig is consistently ranked among the top firms on the Am Law Global 100, NLJ 500, and Law360 400. Greenberg Traurig is also known for its philanthropic giving, culture, innovation, and pro bono work. Web: www.gtlaw.com.